93 related articles for article (PubMed ID: 7256806)
1. [Serum thyroglobulin (S-hTG): a tumor marker in patients with differentiated thyroid carcinoma (author's transl)].
Jänsch A; Heinze HG; Hast B
Strahlentherapie; 1981 Jun; 157(6):381-92. PubMed ID: 7256806
[No Abstract] [Full Text] [Related]
2. [Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].
Botsch H; Schulz E; Lochner B
Dtsch Med Wochenschr; 1979 Jul; 104(30):1072-4. PubMed ID: 467254
[TBL] [Abstract][Full Text] [Related]
3. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
4. [Significance of measurement of serum thyroglobulin in patients with differentiated thyroid carcinoma after total thyroidectomy--a marker of metastases].
Kusakabe K; Ohta Y; Kawasaki Y; Maki M; Hiroe M; Shigeta T; Obara T; Fujimoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 May; 47(5):745-53. PubMed ID: 3658661
[No Abstract] [Full Text] [Related]
5. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
[TBL] [Abstract][Full Text] [Related]
6. High-sensitive 2nd generation thyroglobulin immunoradiometric assay. Clinical application in differentiated thyroid cancer management.
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2002 Dec; 46(4):319-22. PubMed ID: 12411872
[TBL] [Abstract][Full Text] [Related]
7. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma.
Rüter A; Smeds S; Lennquist S
Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785
[TBL] [Abstract][Full Text] [Related]
8. [Determination of serum thyroglobulin in differentiated thyroid cancer. A review and 3 cases].
Feldt-Rasmussen U; Hansen HS; Rasmusson B
Ugeskr Laeger; 1983 Apr; 145(15):1132-6. PubMed ID: 6879741
[No Abstract] [Full Text] [Related]
9. [Human thyroglobulin radioimmunoassay--Preliminary results in serum and thyroid tissue (author's transl)].
Schlumberger M; Fragu P; Vignal A; Tubiana M
Ann Endocrinol (Paris); 1979; 40(4):439-40. PubMed ID: 583204
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma.
Hall FT; Beasley NJ; Eski SJ; Witterick IJ; Walfish PG; Freeman JL
Laryngoscope; 2003 Jan; 113(1):77-81. PubMed ID: 12514386
[TBL] [Abstract][Full Text] [Related]
12. Serum thyroglobulin levels in patients with differentiated thyroid carcinoma.
Van Herle AJ
Ann Radiol (Paris); 1977; 20(8):743-5. PubMed ID: 610543
[No Abstract] [Full Text] [Related]
13. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
Whitley RJ; Ain KB
Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
[TBL] [Abstract][Full Text] [Related]
14. The role of estimation of the ratio of preoperative serum thyroglobulin to the thyroid mass in predicting the behaviour of well differentiated thyroid cancers.
Sharma AK; Sarda AK; Chattopadhyay TK; Kapur MM
J Postgrad Med; 1996; 42(2):39-42. PubMed ID: 9715297
[TBL] [Abstract][Full Text] [Related]
15. Can thyroid peroxidase be used as a complementary tumor marker besides thyroglobulin? Preliminary experience with determination of TPO in differentiated thyroid carcinomas.
Franke WG; Schimming C; Wunderlich G
Anticancer Res; 1997; 17(4B):2999-3002. PubMed ID: 9329585
[TBL] [Abstract][Full Text] [Related]
16. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
[TBL] [Abstract][Full Text] [Related]
17. [Assay of thyroglobulin in the study of patients with differentiated thyroid carcinoma].
Limbert E; Dinarés JM; Santos MA; Henriques MM
Acta Med Port; 1984 Mar; 5(3):73-8. PubMed ID: 6731030
[No Abstract] [Full Text] [Related]
18. [Serum thyroglobulin in the follow-up of patients treated for differentiated carcinoma of the thyroid. Evaluation of factors determining its effectiveness].
García Solís D; Rodríguez Rodríguez JR; Acosta D; Astorga R
Med Clin (Barc); 1986 May; 86(18):748-52. PubMed ID: 3736171
[No Abstract] [Full Text] [Related]
19. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
20. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
